FibroGen Long Term Debt 2013-2025 | FGEN

FibroGen long term debt from 2013 to 2025. Long term debt can be defined as the sum of all long term debt fields.

FibroGen Annual Long Term Debt (Millions of US $)
2024	$73
2023	$72
2022
2021
2020	$25
2019	$38
2018
2017	$98
2016	$97
2015	$97
2014	$97
2013	$96
2012	$92

FibroGen Quarterly Long Term Debt (Millions of US $)
2025-09-30
2025-06-30
2025-03-31	$73
2024-12-31	$73
2024-09-30	$73
2024-06-30	$72
2024-03-31	$72
2023-12-31	$72
2023-09-30	$72
2023-06-30	$71
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30	$0
2021-06-30
2021-03-31	$22
2020-12-31	$25
2020-09-30	$1
2020-06-30	$32
2020-03-31	$35
2019-12-31	$38
2019-09-30	$41
2019-06-30	$44
2019-03-31	$47
2018-12-31
2018-09-30	$97
2018-06-30	$97
2018-03-31	$98
2017-12-31	$98
2017-09-30	$97
2017-06-30	$97
2017-03-31	$98
2016-12-31	$97
2016-09-30	$97
2016-06-30	$97
2016-03-31	$97
2015-12-31	$97
2015-09-30	$97
2015-06-30	$97
2015-03-31	$97
2014-12-31	$97
2014-09-30
2014-06-30
2014-03-31
2013-12-31	$96
2012-12-31	$92

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.036B	$0.030B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$86.093B	32.70
Zoetis (ZTS)	United States	$52.033B	18.62
Takeda Pharmaceutical (TAK)	Japan	$45.725B	9.33
Daiichi Sankyo, - (DSNKY)	Japan	$41.543B	20.69
BeOne Medicines - (ONC)	Switzerland	$38.249B	187.60
Sandoz Group AG (SDZNY)	Switzerland	$32.674B	0.00
United Therapeutics (UTHR)	United States	$20.876B	18.37
Merck (MKKGY)	Germany	$17.661B	10.89
Neurocrine Biosciences (NBIX)	United States	$15.517B	37.23
Shionogi (SGIOY)	Japan	$14.513B	13.33
Summit Therapeutics (SMMT)	United States	$13.834B	0.00
Ionis Pharmaceuticals (IONS)	United States	$12.736B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$12.547B	0.00
IPSEN (IPSEY)	France	$11.918B	0.00
Orion OYJ (ORINY)	Finland	$9.738B	27.82
Corcept Therapeutics (CORT)	United States	$8.974B	96.94
Eisai (ESAIY)		$8.773B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.314B	35.34
Ono Pharmaceutical (OPHLF)	Japan	$6.238B	18.97
Grifols, S.A (GRFS)	Spain	$6.154B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.620B	0.00
Crinetics Pharmaceuticals (CRNX)	United States	$4.561B	0.00
NewAmsterdam Pharma (NAMS)	Netherlands	$4.038B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.975B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$3.838B	18.22
Ocular Therapeutix (OCUL)	United States	$3.283B	0.00
Dyne Therapeutics (DYN)	United States	$2.812B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.802B	8.94
Hypermarcas (HYPMY)	Brazil	$2.787B	19.13
Soleno Therapeutics (SLNO)	United States	$2.686B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.098B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.040B	24.17
Guardian Pharmacy Services (GRDN)	United States	$1.895B	36.49
Harrow (HROW)	United States	$1.859B	114.09
BioCryst Pharmaceuticals (BCRX)	United States	$1.613B	95.75
Collegium Pharmaceutical (COLL)	United States	$1.545B	7.65
Oruka Therapeutics (ORKA)	United States	$1.520B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.453B	0.00
Ardelyx (ARDX)	United States	$1.438B	0.00
Savara (SVRA)	United States	$1.361B	0.00
Relay Therapeutics (RLAY)	United States	$1.316B	0.00
Xencor (XNCR)	United States	$1.225B	0.00
Enliven Therapeutics (ELVN)	United States	$1.197B	0.00
Nektar Therapeutics (NKTR)	United States	$1.175B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.152B	0.00
Cronos Group (CRON)	Canada	$1.068B	0.00
Evotec AG (EVO)	Germany	$1.065B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.032B	0.00
Esperion Therapeutics (ESPR)	United States	$0.916B	0.00
Theravance Biopharma (TBPH)	United States	$0.892B	37.47
KalVista Pharmaceuticals (KALV)	United States	$0.852B	0.00
Aquestive Therapeutics (AQST)	United States	$0.760B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.748B	6.68
Lexeo Therapeutics (LXEO)	United States	$0.710B	0.00
Lyell Immunopharma (LYEL)	United States	$0.665B	0.00
ProKidney (PROK)	United States	$0.653B	0.00
Bioventus (BVS)	United States	$0.621B	12.71
4D Molecular Therapeutics (FDMT)	United States	$0.619B	0.00
Organogenesis (ORGO)	United States	$0.600B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.600B	14.19
Altimmune (ALT)	United States	$0.567B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.555B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.476B	0.00
Siga Technologies (SIGA)	United States	$0.448B	6.13
Akebia Therapeutics (AKBA)	United States	$0.433B	0.00
Nature's Sunshine Products (NATR)	United States	$0.382B	22.75
USANA Health Sciences (USNA)	United States	$0.382B	10.65
Avalo Therapeutics (AVTX)	United States	$0.362B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.354B	0.00
Galectin Therapeutics (GALT)	United States	$0.354B	0.00
Larimar Therapeutics (LRMR)	United States	$0.326B	0.00
Relmada Therapeutics (RLMD)	United States	$0.324B	0.00
Fractyl Health (GUTS)	United States	$0.321B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.296B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.288B	0.00
OmniAb (OABI)	United States	$0.288B	0.00
Pyxis Oncology (PYXS)	United States	$0.267B	0.00
Heron Therapeutics (HRTX)	United States	$0.251B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.245B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.233B	0.00
Protara Therapeutics (TARA)	United States	$0.221B	0.00
Profound Medical (PROF)	Canada	$0.219B	0.00
MediWound (MDWD)	Israel	$0.213B	0.00
AleAnna (ANNA)	United States	$0.211B	0.00
Journey Medical (DERM)	United States	$0.209B	0.00
Surrozen (SRZN)	United States	$0.205B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.180B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.162B	0.00
Gain Therapeutics (GANX)	United States	$0.161B	0.00
Innate Pharma SA (IPHYF)	France	$0.160B	0.00
Cassava Sciences (SAVA)	United States	$0.157B	0.00
Incannex Healthcare (IXHL)	Australia	$0.143B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.111B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.110B	0.00
Vivani Medical (VANI)	United States	$0.108B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.107B	0.00
Avita Medical (RCEL)	United States	$0.107B	0.00
Prelude Therapeutics (PRLD)	United States	$0.104B	0.00
Context Therapeutics (CNTX)	United States	$0.098B	0.00
Plus Therapeutics (PSTV)	United States	$0.092B	0.00
VAXART, INC (VXRT)	United States	$0.087B	0.00
Champions Oncology (CSBR)	United States	$0.085B	30.80
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.084B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.083B	0.00
Rafael Holdings (RFL)	United States	$0.079B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.078B	0.00
Assertio Holdings (ASRT)	United States	$0.075B	0.00
Korro Bio (KRRO)	United States	$0.074B	0.00
Metagenomi (MGX)	United States	$0.068B	0.00
Lite Strategy (LITS)	United States	$0.068B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.067B	0.00
Dominari Holdings (DOMH)	United States	$0.067B	0.00
PolyPid (PYPD)	Israel	$0.064B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
Nutriband (NTRB)	United States	$0.059B	0.00
Talphera (TLPH)	United States	$0.058B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.055B	0.00
Wellgistics Health (WGRX)	United States	$0.055B	0.00
Century Therapeutics (IPSC)	United States	$0.052B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.048B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.039B	0.00
ElectroCore (ECOR)	United States	$0.038B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.037B	31.25
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Klotho Neurosciences (KLTO)	United States	$0.032B	0.00
Inotiv (NOTV)	United States	$0.029B	0.00
Vyome Holdings (HIND)	United States	$0.027B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
Scienture Holdings (SCNX)	United States	$0.026B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.024B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.024B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.023B	0.00
TherapeuticsMD (TXMD)	United States	$0.022B	0.00
Natural Alternatives (NAII)	United States	$0.020B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.020B	0.00
Traws Pharma (TRAW)	United States	$0.020B	0.03
Vivos Therapeutics (VVOS)	United States	$0.020B	0.00
Lipocine (LPCN)	United States	$0.018B	0.00
Mannatech (MTEX)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.016B	0.00
Heatwurx (PCSA)	United States	$0.016B	0.00
Tempest Therapeutics (TPST)	United States	$0.016B	0.00
Mangoceuticals (MGRX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.014B	0.00
VYNE Therapeutics (VYNE)	United States	$0.013B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.013B	0.00
BioVie (BIVI)	United States	$0.012B	0.00
Ainos (AIMD)	United States	$0.010B	0.00
CASI Pharmaceuticals (CASI)	China	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.009B	0.00
Aptorum Group (APM)	United Kingdom	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.007B	0.00
Nuvilex (PMCB)	United States	$0.007B	0.00
ProPhase Labs (PRPH)	United States	$0.007B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Jaguar Animal Health (JAGX)	United States	$0.005B	0.00
Indaptus Therapeutics (INDP)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
CDT Equity (CDT)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Aditxt (ADTX)	United States	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.002B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Indivior (INDV)	United States	$0.000B	18.09
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Minerva Neurosciences (NERV)	United States	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00